Threlfall E J, Cheasty T, Graham A, Rowe B
Laboratory of Enteric Pathogens, Central Public Health Laboratory, London, UK.
Int J Antimicrob Agents. 1997 Jan;9(3):201-5. doi: 10.1016/s0924-8579(97)00055-1.
A study of the incidence of resistance to antimicrobial drugs in Escherichia coli from blood and CSF made in England and Wales in the 6-year period 1991 1996 has demonstrated a significant increase in the incidence of strains resistant to ampicillin and ciprofloxacin, two antibiotics used for first-line therapy of invasive disease. In particular, there has been a dramatic change in the occurrence of isolates with low level or high level resistance to ciprofloxacin; over 90% of isolates in the high level group were also resistant to at least four other antimicrobials. Physicians in England and Wales should be aware that there is now an increasing possibility of treatment failures when ciprofloxacin is used for the treatment of invasive E. coli infections.
1991年至1996年期间在英格兰和威尔士开展的一项关于血液和脑脊液中大肠杆菌对抗菌药物耐药性发生率的研究表明,对氨苄西林和环丙沙星这两种用于侵袭性疾病一线治疗的抗生素耐药的菌株发生率显著增加。特别是,对环丙沙星具有低水平或高水平耐药性的分离株的出现情况发生了巨大变化;高水平组中超过90%的分离株还对至少其他四种抗菌药物耐药。英格兰和威尔士的医生应该意识到,现在使用环丙沙星治疗侵袭性大肠杆菌感染时治疗失败的可能性越来越大。